SFY 2019 - 2020 MC BHET Report Summary
HIV SNP line of business
- Document also available in Portable Document Format (PDF)
| Plan | BHET % | BHET Target Expense | BHET Experience | Remittance | MMs | |
|---|---|---|---|---|---|---|
| Amida Care Inc. | 141.27% | $14,820,739 | $20,937,566 | $0 | 76,074 | |
| MetroPlus Health Plan, Inc | 79.81% | $8,293,039 | $6,618,936 | $1,342,382 | 41,140 | |
| VNS (d/b/a VNSNY Choice) and Subsidiary | 86.90% | $7,217,721 | $6,272,071 | $656,942 | 34,751 | |
| Total | $30,331,499 | $33,828,572 | $1,999,324 | 151,965 |
NOTES:
BHET Target 96%
